HOME >> MEDICINE >> NEWS
Novel Imaging Agent Developed By Penn Researchers Provides Insight Into Brain's Message Delivery System

(Philadelphia, PA) -- How the brain works and why it malfunctions remains a mystery that drives scientists and physicians to seek answers. A scientific triumph in this crusade occurred when an advanced brain imaging agent, called Trodat, was developed at the University of Pennsylvania Medical Center. This imaging agent could be a key to the understanding of brain disorders like Parkinson's and Alzheimer's diseases.

To acknowledge this milestone, the European Journal of Nuclear Medicine (EJNM) will present one of its highest honors -- the Award for Best Science Paper in 1997-- to Hank F. Kung, PhD, professor and Chief of Radiopharmaceutical Research at the University of Pennsylvania Medical Center. The award will be given at the Joint Congress of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology held in Berlin, Germany, August 30 - September 4, 1998.

This award recognizes the breakthroughs of Dr. Kung and a multi-disciplinary team of researchers at Penn, including chemists, radiologists, psychiatrists, and pharmacologists. The paper, entitled, "[99mTc] Trodat-1: a Novel Technetium-99m Complex as a Dopamine Transporter Imaging Agent*," describes the development and study of a groundbreaking new brain tracer, or imaging agent, used to evaluate brain function in normal and disease states. Commonly known as Trodat, this new tracer is a derivative of tropane -- a minimally-radioactive chemical that follows the flow of a chemical messenger in the brain called dopamine -- and can be used as a diagnostic tool for imaging dopamine transporters.

"The dopamine system in the brain contains receptors that control basic functions like ovement, memory, and emotion," explains Dr. Kung. "Trodat can be used to determine whether the dopamine transporter is working correctly, or, if it is unbalanced which leads to neurological and psychological illnesses th
'"/>

Contact: Diane Giaccone
dgiaccon@mail.med.upenn.edu
(215) 662-2098
University of Pennsylvania School of Medicine
25-Aug-1998


Page: 1 2 3

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
Breaking Medicine Technology:
Cached News: